Brello Health review
Low price, real commitment
A telehealth platform publishing the lowest sermorelin and NAD⁺ figures in this batch — as the monthly equivalent of a three-month supply billed upfront.
Our verdict
Brello Health publishes the cheapest sermorelin and NAD⁺ numbers we found across this batch, and it enumerates its coverage honestly at 34 states plus DC rather than implying the whole country. Read the structure before the number: those are per-month equivalents of a three-month supply billed as one upfront charge, on plans that renew every 11 weeks. The 503A pharmacy is unnamed and no prescribers are disclosed.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- NAD⁺ $79/mo (from $117) billed as a 3-month supply; 34 states plus DC
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- 34 states plus DC
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
Brello Health is a direct-to-consumer telehealth platform whose menu covers compounded GLP-1 weight loss and a longevity line of sermorelin, NAD⁺ and a lipotropic MICC injection, plus bundles that combine them. Coverage is stated as 34 states plus Washington DC, with the unavailable states identified rather than left vague. Plans bundle the medication, a provider health review, injection supplies, virtual fitness and nutrition classes, a member community and app-based progress tracking, and medication ships from a US-based 503A compounding pharmacy.
How it works
Online intake, provider review, then medication shipped in five to seven business days, with the ongoing support built around virtual classes, a member community and app tracking rather than one-to-one clinical contact — worth knowing, because group classes are not coaching. The commitment structure is the thing to understand before anything else: every plan carries a three-month minimum billed as a single upfront charge, and the site describes plans as renewing every 11 weeks, so the cadence is not a calendar month. Cancellation is described as available at any time after the initial period, but the specific method is not published. On disclosure, Brello does the state list well and little else: the 503A compounding pharmacy is not named, no prescribers or medical director are identified, and no LegitScript or BBB accreditation is shown. There is no lab work in the default path before a growth-hormone-axis peptide.
Pricing transparency
Brello publishes sermorelin at $116/mo against a stated regular price of $199, and NAD⁺ at $79/mo against $117, with a MICC injection cheaper still and bundles that pair the longevity products with a GLP-1. Those are the lowest published sermorelin and NAD⁺ figures in this batch and they come with a real condition attached, stated on the site: the plans shown reflect the monthly cost when billed as a three-month supply. So the first charge is the three-month total, not the monthly figure, and the plan renews every 11 weeks rather than monthly — which means roughly 4.7 renewal cycles a year, not four. The discounted-from framing is a marketing device, so confirm what you pay once any promotion lapses, and confirm how to cancel before you commit, since the method is not published.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Brello states its medication ships from a US-based 503A compounding pharmacy and does not name it — 503A facilities compound for individual patients and operate under different oversight from 503B outsourcing facilities, so knowing the category is genuinely more than most disclose and knowing the name would be better. On the evidence, the longevity line splits three ways and the price list does not. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism with thin long-term human outcome data and no controlled trial behind the recovery or body-composition claims. Injectable NAD⁺ has no controlled human outcome trials at all; the oral precursors NR and NMN are the studied forms, and what they demonstrate is a raised blood NAD⁺ level rather than a clinical benefit. The MICC lipotropic injection has essentially no controlled human outcome evidence for fat loss. Bundling all three into one discounted monthly figure makes them look like one product; they are three different evidence stories. Individual results vary.
Pros and watch-outs
What we like
- The lowest published sermorelin and NAD⁺ figures in this batch, both listed openly
- State coverage enumerated at 34 states plus DC, with unavailable states identified
- Plans bundle the medication, provider review, injection supplies and app tracking in one price
- Discloses that its pharmacy is a US-based 503A compounding facility
- Bundle options if you want a GLP-1 and a longevity peptide together
Watch-outs
- Three-month minimum billed as a single upfront charge — the monthly figure is not the first charge
- Plans renew every 11 weeks rather than monthly, so there are more cycles per year than you might assume
- The 503A compounding pharmacy is not named, and no prescribers or medical director are disclosed
- No LegitScript or BBB accreditation shown, and the cancellation method is not published
- Ongoing support is virtual classes and a community, not one-to-one clinical contact
Best for
Price-led buyers in one of its 34 states who want sermorelin or NAD⁺ at the lowest published figure and can absorb a three-month upfront charge.
Who should look elsewhere
Anyone unwilling to prepay a quarter at a time, anyone outside its stated coverage, or anyone who wants a named pharmacy and identified prescribers.
The evidence behind what Brello Health prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
How Brello Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
EdenSermorelin in an oral fast-dissolve (ODT) alternative to injections
See Eden →- Luvo Health
Prescription NAD⁺ as an injection, drops or nasal spray at one flat price
See Luvo Health → 
Invigor MedicalPrescription at-home NAD⁺ injections via telehealth
See Invigor Medical →
Research & data · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Brello Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does sermorelin cost at Brello Health?
- It publishes sermorelin at $116 per month against a stated regular price of $199, and NAD⁺ at $79 against $117. The site states those monthly figures reflect billing as a three-month supply, so your first charge is the three-month total rather than the monthly number.
- How does the three-month commitment work?
- Every plan carries a three-month minimum billed as one upfront payment, and plans are described as renewing every 11 weeks — which is more than four cycles a year, not fewer. Cancellation is described as available after the initial period, but the specific method is not published, so confirm it with support before enrolling.
- Where is Brello Health available?
- In 34 states plus Washington DC. It identifies the states it does not serve rather than leaving coverage vague, which is better practice than most of this board. Confirm your state before going further.
- Is a cheap sermorelin-and-NAD⁺ bundle a good deal?
- On price, possibly. On evidence, the bundle merges three different stories: sermorelin has a real growth-hormone-axis mechanism with thin outcome data, injected NAD⁺ has no controlled human outcome trials, and the MICC lipotropic injection has essentially no controlled outcome evidence for fat loss. A single discounted figure makes them look equivalent. They are not.